Management of Tongue Swelling After Ultomiris Infusion
Immediately stop the Ultomiris infusion and treat this as a Grade 2-3 infusion-related reaction with angioedema, requiring aggressive symptomatic management with H1/H2 antihistamines, corticosteroids, and close airway monitoring. 1
Immediate Actions
Stop the Infusion and Assess Severity
- Discontinue Ultomiris immediately upon recognition of tongue swelling 2
- Maintain IV access for medication administration
- Assess ABCs (Airway, Breathing, Circulation) - tongue swelling represents potential airway compromise 1
- Position patient sitting upright if respiratory distress is present 1
Determine if Anaphylaxis is Present
Tongue swelling (angioedema) is a serious infusion-related reaction that may progress to anaphylaxis. Evaluate for:
- Respiratory compromise (dyspnea, bronchospasm, stridor)
- Hypotension or cardiovascular instability
- Involvement of other areas (lips, face, throat) 3, 1
Pharmacologic Management
If Anaphylaxis Suspected (Grade 3-4 Reaction)
Administer immediately:
- Epinephrine 0.2-0.5 mg IM (1 mg/mL dilution) into lateral thigh; repeat every 5-15 minutes as needed 1
- Normal saline 1-2 L IV at 5-10 mL/kg in first 5 minutes 1
- Diphenhydramine 50 mg IV plus ranitidine 50 mg IV (H1/H2 blockade) 1
- Methylprednisolone 1-2 mg/kg IV every 6 hours 1
If Non-Anaphylactic Infusion Reaction (Grade 2)
Administer:
- Diphenhydramine 50 mg IV plus ranitidine 50 mg IV 1
- Methylprednisolone 1-2 mg/kg IV every 6 hours 1
- Consider epinephrine if progression occurs
Monitoring Requirements
- Monitor for at least 1 hour after infusion completion per FDA labeling 2
- Extended observation for 24 hours recommended after severe reactions 1
- Watch for biphasic reactions (corticosteroids help prevent these) 1
- Continuously assess airway patency - be prepared for emergency intubation if tongue swelling progresses
Decision on Future Ultomiris Dosing
Grade 2 Reaction (Isolated Angioedema Without Airway Compromise)
After symptom resolution:
- May attempt rechallenge with aggressive premedication 1
- Restart at 50% infusion rate and titrate to tolerance 1
- Shared decision-making with patient regarding risk/benefit 3
Grade 3-4 Reaction (With Respiratory Symptoms or Hypotension)
- Permanently discontinue Ultomiris 1
- Do not attempt rechallenge - risk of severe recurrent reaction is high 3, 1
Premedication for Future Doses (If Rechallenge Attempted)
If continuing Ultomiris after Grade 2 reaction:
- Methylprednisolone 100 mg IV 1 hour before infusion 1
- Diphenhydramine 25-50 mg (oral or IV) 1
- Acetaminophen 650-1000 mg orally 1
- Slower infusion rate (50% of standard) 1
Important Caveats
Distinguish from other causes of tongue swelling:
- ACE inhibitor-induced angioedema (if patient on these medications) 4, 5
- Hereditary angioedema
- Allergic reactions to other medications
Document the reaction thoroughly including:
- Time of onset relative to infusion start
- Severity and progression
- Response to treatment
- This guides future management decisions 1
The FDA label specifically mentions angioedema as a potential infusion-related reaction symptom requiring immediate evaluation 2. While Ultomiris infusion reactions are generally manageable, angioedema involving the tongue represents a Grade 2-3 severity reaction that mandates aggressive treatment and careful consideration before any rechallenge attempt.